the timing of covid-19 transmission - medrxiv€¦ · 04/09/2020 · perpetuity. 1 the timing of...

1

The timing of COVID-19 transmission LucaFerretti1,AliceLedda2,ChrisWymant1,LeleZhao1,VirginiaLedda3,LucieAbeler-Dörner1,MichelleKendall1,AnelNurtay1,Hao-YuanCheng4,Ta-ChouNg5,Hsien-HoLin5,RobHinch1,JoannaMasel6,A.MarmKilpatrick7,ChristopheFraser1

1BigDataInstitute,LiKaShingCentreforHealthInformationandDiscovery,NuffieldDepartmentofMedicine,UniversityofOxford,UK

2MRCCentreforGlobalInfectiousDiseaseAnalysis,DepartmentofInfectiousDiseaseEpidemiology,SchoolofPublicHealth,ImperialCollegeLondon,UK

3LiverpoolUniversityHospitalsNHSFoundationTrust,UK

4EpidemicIntelligenceCenter,TaiwanCentersforDiseaseControl,Taipei,Taiwan

5InstituteofEpidemiologyandPreventiveMedicine,NationalTaiwanUniversityCollegeofPublicHealth;GlobalHealthProgram,NationalTaiwanUniversityCollegeofPublicHealth,Taipei,Taiwan

6Ecology&EvolutionaryBiology,UniversityofArizona,USA

7Ecology&EvolutionaryBiology,UniversityofCalifornia,SantaCruz,USA

Abstract:ThetimingofSARS-CoV-2transmissionisacriticalfactortounderstandtheepidemic trajectory and the impact of isolation, contact tracing and other non-pharmaceutical interventionsonthespreadofCOVID-19epidemics.Weexaminedthedistributionoftransmissioneventswithrespecttoexposureandonsetofsymptoms.Weshowthatforsymptomaticindividuals,thetimingoftransmissionofSARS-CoV-2ismorestrongly linked to the onset of clinical symptoms of COVID-19 than to the time sinceinfection.Wefoundthatitwasapproximatelycenteredandsymmetricaroundtheonsetofsymptoms,withthreequartersofeventsoccurringinthewindowfrom2-3daysbeforeto2-3daysafter.However,wecautionagainstoverinterpretationoftherighttailofthedistribution,due to itsdependenceonbehavioural factorsand interventions.Wealsofound that the pre-symptomatic infectious period extended further back in time forindividualswithlongerincubationperiods.Thisstronglysuggeststhatinformationaboutwhenacasewasinfectedshouldbecollectedwherepossible,inordertoassesshowfarintothepasttheircontactsshouldbetraced.Overall,thefractionoftransmissionfromstrictlypre-symptomatic infectionswashigh (41%;95%CI31-50%),which limits theefficacyofsymptom-basedinterventions,andthelargefractionoftransmissions(35%;95%CI 26-45%) that occur on the same day or the day after onset of symptomsunderlinesthecritical importanceof individualsdistancingthemselves fromothersassoonastheynoticeanysymptoms,eveniftheyaremild.Rapidorat-hometestingandcontextualriskinformationwouldgreatlyfacilitateefficientearlyisolation.

Introduction TheCOVID-19diseaseemergedattheendof2019.Severalmonthsafterthefirstreportsonthedisease,ourunderstandingoftransmissionofthecausativevirus-SARS-CoV-2-

All rights reserved. No reuse allowed without permission. perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for thisthis version posted September 7, 2020. ; https://doi.org/10.1101/2020.09.04.20188516doi: medRxiv preprint

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

https://doi.org/10.1101/2020.09.04.20188516

2

isstillincomplete.Adetailedknowledgeofitstransmissionisurgentlyneededtoimprovepublichealthinterventionsaimedatreducingtheburdenofthepandemiconsocieties.Inparticular,thetemporalprofileofinfectiousnessinrelationtotheonsetofsymptomsis crucial for assessing and optimising public health interventions and minimisingdisruptiontosocietyandtheeconomy.

Whendesigning interventionstocontrolacommunicablediseasesuchasCOVID-19,akey quantity is the fraction of transmissions occurring while the source is non-symptomatic(Fraseretal.2004;Peaketal.2017),i.e.eitherpre-symptomatic(beforesymptomonset)orasymptomatic(forindividualswhoneverdevelopsymptoms).

Symptomaticindividualsareeasierto(self-)identifyandtheycantakemeasurestoavoidspreadingthevirus,whereastransmission fromnon-symptomatic individuals ismuchmoredifficulttoprevent.Theextentandtimingofnon-symptomatictransmissionhavealargeimpactonwhichpublichealthinterventionscanbeeffectiveandhowtheyshouldbe implemented (Fraser et al. 2004; Peak et al. 2017). For example, isolation ofsymptomaticcasesmaybesufficienttopreventspreadforadiseasethatistransmittedonly after onset of clinical symptoms, as was the case with SARS (May et al. 2004);however,furtherinterventionsmaybenecessaryforadiseasewithahighproportionofnon-symptomatic transmission such as COVID-19. In the latter case, preventingtransmission from non-symptomatic individuals requires actively finding suchindividualsthroughcontacttracing(Ferrettietal.2020)ormasstesting(Larremoreetal. 2020), and/ormeasures targeting the entire population such as facemasks, handhygiene,andvaryingdegreesofphysicaldistancing.Hence,knowingthecontributionofnon-symptomatictransmissioniskeyforthechoiceofinterventions.

ThefractionofallCOVID-19transmissionsthatcomefromasymptomaticindividualsisdifficulttomeasureinanunbiasedmanner;inaddition,itislikelydependentontheageof infected individuals and therefore time- and population-specific. Indirect evidencesuggeststhatasymptomaticindividualsarelessinfectiousthansymptomaticindividuals(Zhouetal.2020;Leeetal.2020;Madewelletal.2020)andaccountedforlessthanhalfof infectionsof SARS-COV-2 inChinaandEuropeancountries in the firsthalfof2020(Pollánetal.2020;Lavezzoetal.2020;Buitrago-Garciaetal.2020).

Another challenge for public health interventions is the occurrence of transmissionsbefore or shortly after symptom onset, from individuals who do develop symptomsduring the course of the infection: pre-symptomatic and early symptomatictransmissionshereafter.Pre-symptomatictransmissionshavebeenestimatedtoaccountforalmosthalfofallnon-asymptomatictransmissions(seee.g.meta-analysisin(Caseyetal.2020)).

The timing of pre-symptomatic and early symptomatic transmission determines thespeed required for finding the contacts who could have been infected, before thesecontacts,inturn,infectothers.Iftheintervalfrominfectiontoonsetofsymptomsisjustafewdays,asseemstobethecaseforCOVID-19,itbecomescriticaltonotifycontactsinstantlywhen the index case is confirmed by rapid testing or even symptom-basedclinicaldiagnosis.Thereforedigitalcontacttracingviaasmartphoneapp,whichmakesthe exposure notification step of contact tracing instantaneous, could substantiallyenhance the effectiveness of traditionalmanual contact tracing (Ferretti et al. 2020;Kucharskietal.2020;Braithwaiteetal.2020;Anglemyeretal.2020).Effectivenessofdigitalcontacttracingdependsonmanyfactors(Hinchetal.2020)includingthefraction



https://doi.org/10.1101/2020.09.04.20188516

3

ofthepopulationinstallingtheapp,andonhowclusteredorcorrelatedappuseiswithincommunities (Farronato et al. 2020), the time until diagnosis and notification(Kretzschmaretal.2020),andthecompliancewithquarantinerecommendations.

Bothtraditionalanddigitalcontact tracingrequireareliableestimateof thetemporalprofile of infectiousness in order to assesswhich contacts are at risk of having beeninfected and which are not. Assessing the risk of exposed contacts as accurately aspossible is key tomaximising the numberof infectious individuals in quarantine andpreventing further spread,whileminimising thenumberofnon-infectious individualsunnecessarilyquarantined.

In this study we examine the temporal profile of infectiousness for SARS-CoV-2.Weestimate the distributions for the lengthof the intervals between infection, symptomonset and transmission using multiple datasets containing information on 191transmissionpairs.Wefindthatthetimingoftransmissioneventsdependsmorestronglyononsetofsymptomsthantimesinceinfection.Infectiousnessreachesitspeakneartheonsetofsymptoms,afterincreasinggraduallyfromthetimeofinfection.Weestimatethefractionofpre-symptomatictransmissions,andtherelativeimportanceoftransmissionsbeforeandshortlyafterthetimeofsymptomonset.Finally,weoutlinetherelevanceofthesefindingsforcontacttracing,timingofisolationandotherindividualprecautionarymeasures.

Time intervals

The temporalprofileofCOVID-19 infectionand transmission is characterisedby fourepidemiologicallyrelevanttimeintervals(Table1andFigure1):theincubationperiod,the serial interval, the generation time and the time from onset of symptoms totransmission(TOST).Thesefourtimeintervalsaredelimitedbyfourkeytimepoints:thetimeatwhichanindividualgetsinfected,thetimeatwhichtheyinfectanotherindividual,thetimesatwhichthesourcedevelopssymptomsandatwhichtherecipientdoes.Withthe exception of the incubation period,which is defined for a single individual, theseintervalsaredefinedforatransmissionpair:anindex(primary)caseandasecondarycaseinfectedbytheindex.

Theincubationperiodisthetimebetweeninfectionandonsetofsymptoms.Fromtheaverageofmultipledistributionsfromtheliterature(seeMethods),itsmeanis5.7daysanditsSDis3.5days.

The serial interval is the interval between times of onset of symptoms in index andsecondary cases. It canbedirectlymeasured from thedata, andhasbeenextensivelystudiedforCOVID-19(Griffinetal.2020;Nishiura,Linton,andAkhmetzhanov2020;Duetal.2020;Tindaleetal.2020),althoughitcanbeaffectedbyseveralbiases(Parketal.2020).Itisoccasionallynegative-whenthesecondarycasedevelopssymptomsbeforetheindexcase.Itisundefinedifeithercasehasanasymptomaticinfectionordoesnotreportsymptoms.

Thegenerationtimeistheintervalbetweenthetimeofinfectionoftheindexcaseandthetimeofinfectionofthesecondarycase.Itistypicallyhardertoestimatedirectlyunlesstheintervalofexposureisshortforbothindexandsecondarycase.Thegenerationtimeisusuallyinferredindirectlyfromintervalsofexposureandonsetofsymptoms.Ithas



https://doi.org/10.1101/2020.09.04.20188516

4

been inferred forCOVID-19by (Ferretti et al. 2020;Ganyani et al. 2020). It is alwayspositivebydefinition.

TOST is the time elapsed between the onset of symptoms in the index case, and thetransmissionfromindextosecondarycase.Itispositiveforsymptomatictransmissionandnegativeforpre-symptomatictransmissionbydefinition.Itisundefinediftheindexcasehasanasymptomaticinfectionordoesnotreportsymptoms.Thistimeintervalhasrarelybeendiscussedinepidemiology,althoughithasbeenconsideredforCOVID-19(Heetal.2020;Ashcroftetal.2020).

Knowledge of these four intervals enables us to predict the relative effectiveness ofdifferentinterventions,e.g.physicaldistancing,wearingoffacemasks,masstestingorcontacttracing.

Table1: Four time intervals that influence control via isolationof symptomaticindividuals.

Timeinterval From ToIncubationperiod infection → onsetofsymptomsGenerationtime infection → transmission(secondary)TOST onsetofsymptoms → transmission(secondary)Serialinterval onsetofsymptoms → onsetofsymptoms(secondary)

Results

Serial interval

Weanalysedtransmissionpairsfromtheonlyfourdatasetsintheliterature(Ferrettietal.2020;Xiaetal.2020;Chengetal.2020;Heetal.2020)thatcontainthedateofonsetof symptoms for both index and secondary cases, as well as partial information onintervalsof exposure.To test the robustnessof the results,we includedanadditionaldatasetby(Zhangetal.2020)withserialintervalsonly.

Theempiricalserialinterval,whenanalysingallfivedatasetscombined,hadameanof5.1days,amedianof4days,andastandarddeviationof3.8days;themeanwas4.1dayswithoutZhangetal.Theseresultsareconsistentwithotherstudies(Tindaleetal.2020;Duetal.2020;Bietal.2020).Moststudiesfitalognormaldistributiontothedata,eventhough serial intervals are occasionally negative. The empirical distribution and thelognormal distributionwith the samemean and SD are illustrated in SupplementaryFigure1.Thereare,however,manycaveatsinusingtheserialintervaldistributionforepidemiologicalinference(Parketal.2020).

Themedianoftheserialintervalwassimilaracrossdifferentdatasets(allp>0.2,Mann-WhitneyU-test)butthevariancewasdifferent,withFerretti&WymantetalandChengetalshowingsignificantunderdispersionandoverdispersionwithrespecttotheothers(p=0.001and0.025respectively,Fligner-Killeentest).14outof40transmissioneventsfromFerretti&Wymantetaloccurredduringaphaseofexponentialepidemicgrowth,



https://doi.org/10.1101/2020.09.04.20188516

5

whenthecorrespondingserialintervalisexpectedtobeshorter(Svensson2007).Weexplicitlycorrectedforthiseffectintheinferenceofgenerationtimeinthenextsection.

Generation time

Weinferredthegenerationtimedistributionbymaximumlikelihoodestimation,usingdatesofonsetofsymptomsforbothindexandsecondarycases,aswellastheirintervalsofexposure(whenavailable).Wecorrectedforexponentialgrowthandrightcensoring,asdetailedintheMethods.

Todeterminethefunctionalformofthedistribution,wetestedawiderangeofpossibleshapesthatareconsistentwiththenear-absenceofinfectiousnessoftheindexcaseatthetimeofinfection.Thisrequirementstemsfromtheverylowinitialviralload,sinceeachcycleofviralreplicationtakesseveralhours(Bar-Onetal.2020).

Thebest-fittingshape,asdeterminedbytheAkaikeInformationCriterion(AIC),wasaWeibull distribution (Figure 1A; mean 5.5 days, standard deviation 1.8 days). AGompertz,a log-logisticandagammadistributionprovidedgoodfitsaswell (𝛥𝐴𝐼𝐶 =0.57, 0.93 and 1.06 respectively, Supplementary Table 1). The generation timedistributions corresponding to the best parameter fits for each shape are shown inSupplementaryFigure2,andthemaximum-likelihoodparametervaluesforeachshapeinSupplementaryTable2.

Given the heterogeneity among datasets in terms of interventions and stage of theepidemic, it is important toassess therobustnessof the inferencewithrespect to thechoiceofdatasets.Were-inferredthegenerationtimedistributionremovingonedatasetatatime,aswellasaddingtheadditionaldatasetbyZhangetal.Theresultswerequiterobustandwithintheuncertaintiesoftheinference,asillustratedinFigure1A.



https://doi.org/10.1101/2020.09.04.20188516

6

Figure1:Top: illustrationof thedefinitionsofepidemiologicallyrelevanttime intervals.Bottom:maximum-likelihooddistributionsof(A)generationtimeand(B)TOST,excludingorincludingdifferentdatasets,shownwithdifferentcolours.Thepointwise95%CIforthefittothebaselinedataset(‘full’,whichdoesnotincludeZhangetal.)isshowningrey.Thedashedblacklineshowstheincubationperioddistributionforcomparison.

Time from onset of symptoms to transmission (TOST)

WeinferredthedistributionforTOSTbymaximumlikelihoodestimation.AsCOVID-19isoftentransmittedpre-symptomatically(negativeTOST),weconsidereddistributionswhich include both positive and negative times. The best fit was given by a scaledStudent’s t distribution (Fig. 1B; mean=-0.07 days, SD=2.8 days). A skew-logisticdistribution (mean=0.02 days, SD=2.65 days) also provided a good fit (𝛥𝐴𝐼𝐶 = 0.65;SupplementaryTable3).TheTOSTdistributionscorrespondingtothebestparameterfitsfor each shape are shown in Supplementary Figure 3, and the parameter values inSupplementaryTable4.

Wetestedtherobustnesswithrespecttochoiceofdatasetsbyremovingonedatasetatatimeandaddinganadditionaldatasetasbefore.Allbest-fitdistributionswerecenteredaroundthetimeofonsetofsymptomswithroughlysimilarwidth(Figure1B).

1

Infected

Incubation period

Generation time

2

Symptomatic

Symptomatic

Infected

TOST

Serial interval

0.0

0.1

0.2

0.3

0 5 10 15Generation time (days)

Prob

abilit

y de

nsity

(per

day

)

A

0.1

0.2

0.3

-5 0 5 10TOST (days)

Prob

abilit

y de

nsity

(per

day

)

Dataset:full

full - Cheng et al

full - Ferretti et al

full - He et al

full - Xia et al

full + Zhang et al

B

0.0

0.1

0.2

0.3

0 5 10 15Generation time (days)

Prob

abilit

y de

nsity

(per

day

)

A

0.1

0.2

0.3

-5 0 5 10TOST (days)

Prob

abilit

y de

nsity

(per

day

)

Dataset:full

full - Cheng et al

full - Ferretti et al

full - He et al

full - Xia et al

full + Zhang et al

B



https://doi.org/10.1101/2020.09.04.20188516

7

The peak of infectiousness depends on the onset of symptoms rather than the time of infection

Ithaspreviouslybeennotedthatthesimilaritybetweenthemeanincubationperiodandthemeangenerationtime(about5.5days)suggestsameanTOSTofclosetozeroi.e.analmost-centereddistributionofTOST(Nishiura,Linton,andAkhmetzhanov2020;Caseyet al. 2020). Transmission events are indeed clearly concentrated around the time ofonset of symptoms, regardless of the details of the inference. This can be either acoincidence,withnorelationbetweengenerationtimeandincubationperiod(symptom-independentinfectiousness),orthetimesinceonsetofsymptomscoulddeterminetheinfectiousnessofanindividual,ratherthanthetimesincetheindividualwasfirstinfected(symptom-dependentinfectiousness).ThesetwoscenariosareillustratedinFigure2Aand2Brespectively.

Figure2:Threealternativehypothesesforthetimingofinfectiousnessoftheblueindividual(and individuals generally). In (A), infectiousness depends on the time since infection,regardless of whether symptoms develop quickly (A top) or slowly (A bottom). In (B),infectiousnessdependsonthetimeoftheonsetofsymptoms,regardlessofwhetherthetimesinceinfectionisshort(Btop)orlong(Bbottom).In(C),infectiousnessdependsonthetimeofonsetofsymptoms,butitincreasesgraduallyfromthetimeofinfection,thereforeleadingtoashorterinfectiousperiodifsymptomsdeveloprapidly(Ctop)andalongerinfectiousperiodifsymptomsappearlate(Cbottom).

We tested which of these two scenarios, i.e. symptom-dependent and symptom-independentinfectiousness,bestfitourdataontransmissionpairs,usingtheinformationontheintervalofexposureoftheindexandsecondarycasescomparedwiththetimeof

A

infection transmissionsymptom onset symptom onset

infectiousness

B

C

infection

symptom onset

transmission



https://doi.org/10.1101/2020.09.04.20188516

8

onsetofsymptomsoftheindex.ComparingtheAICvaluesinSupplementaryTablesFandGforthemostdirectlyinformativedatasets(Ferretti&Wymantetal,Xiaetal,andbothcombined),wefoundcleardifferencesbetweenthebestfitsforsymptom-dependentandsymptom-independent infectiousness (𝛥𝐴𝐼𝐶 = -13.9, -11.1, -22.4 for the differentdatasets respectively; Supplementary Table 5). Even the simplest Gaussian fit forsymptom-dependentinfectiousnesswasamuchbetterfittothedatathananychoiceofgeneration time distribution for symptom-independent infectiousness (𝛥𝐴𝐼𝐶 = -5.4, -11.1,-18.8).

These results confirm the observation that for individuals that eventually developsymptoms, the period of SARS-CoV-2 infectiousness is directly related to onset ofsymptoms rather than being independent of it. For symptomatic individuals, mosttransmissioneventsoccurredinarangeofafewdaysbeforeandafteronsetofsymptoms.Morethan5daysbeforesymptomonset,infectiousnessappearedtodecreasebelowatenthofitspeakvalue,andweobservedonlyafewpercentoftransmissionsbeyond5daysaftersymptomonset.

Infectiousness increases gradually from time of infection to onset of symptoms Our analyses suggest that time of symptom onset is the main determinant of whentransmissionoccurs,withtransmissionpeakingbeforeandaftertheonsetofsymptoms.However,theincubationperiodcouldstillaffectthewidthofthedistributionofthetimeoftransmissionevents.Indeed,thedatasuggestaweaknegativecorrelationbetweentheincubationperiodofthesourceandtheserialintervalofthepair(SupplementaryFigure4),whichwouldnotbeexpectedifthetimingoftransmissionwasdeterminedonlybytheTOST(seeMethods).

To examine the possibility that the length of the infectious period depends on theincubation period (incubation/symptom-dependent infectiousness), we consideredseveralpossibledependenciesbetweentheTOSTdistributionandtheincubationperiod.Wemodelledthembyrescalingthetimeoftransmissionbyafactordependentontheincubationperiod,affectingeitherthewholedistributionoritsleftpartonly(detailsinMethodsandSupplementaryTable5).

Themodelofincubation/symptom-dependentinfectiousnesswiththebestfitacrossalldatasetswasalinearrescalingofpre-symptomaticvaluesofTOSTbythelengthoftheincubationperiod(Figure2C;𝛥𝐴𝐼𝐶 =0,-9.3,-10.2,-15.5forFerretti&Wymantetal,Xiaetal,bothcombined,andalldatasetscombined,respectively).Inotherwords,individualswithlongerincubationperiodsalsotendtohaveaproportionallyearlierandlongerpre-symptomatic infectious period (Figure 3A). The profiles of transmission for differentincubationperiodsinrelationtoTOSTaredepictedinFigure3B.ThebestfitforTOSTisprovided by a rescaled skew-logistic distribution as a functionof theTOST 𝑡 and theincubationperiod𝑡(:

𝑝*+,*(𝑡|𝑡() ∝𝑒2(*23)/5

(1 + 𝑒2(*23)/5)89:𝑓𝑜𝑟𝑡 ≥ 0,

𝑒2(*23)/(5*B/C)

(1 + 𝑒2(*23)/(5*B/C))89:𝑓𝑜𝑟𝑡 < 0



https://doi.org/10.1101/2020.09.04.20188516

9

withparameters𝜇 = −4.00days,𝜎 = 1.85days,𝛼 = 5.85.Theconstant𝜏 = 5.42daysisthemeanincubationperiodaccordingto(McAloonetal.2020).Foranincubationperiod𝑡( = 𝜏,theTOSThasameanof0.1daysandSDof2.4days.

Figure 3: probability of transmission as a function of generation time (left) and TOST(right)foragivendurationoftheincubationperiod,relativetothepeakprobability.Theblack linerepresents theaveragewithrespect to the incubationperioddistribution.Theenvelopescorrespondtothepointwise95%CI.

Itisunclearwhetherthemagnitudeofinfectiousnessdependsontheincubationperiod.Itispossiblethatanearlyhostimmuneresponsecouldinitiallyreduceviralreplication,butonceinitialbarriersofimmunityareovercome,thesamepeakinfectiousnesscouldbereached.Thiswouldmeanthatindividualswithlateronsetofsymptomshavealongerinfectiousperiodwiththesamepeakinfectiousness;i.e.theircumulativeinfectiousnessincreaseswiththedurationoftheirincubationperiod.Ourdatasetcannotdiscriminatebetween this scenario and the onewhere cumulative infectiousness does not changedependingonthelengthoftheincubationperiod(SupplementaryTable5).Irrespectiveofthis,theaveragedistributionofTOSToveralldurationsoftheincubationperiodisverysimilartothepreviousfit(SupplementaryFigure5).

Sincethetimeofsymptomonsetisthemaindeterminantofinfectiousness,wenoticeastrong positive correlation between incubation period and generation time, which isclearlyvisibleinFigure3A,andaweakernegativeonebetweenincubationperiodandTOST(SupplementaryTable6).

Epidemiological biases could affect symptomatic transmissions

Manybiases can potentially affect the shape of the temporal profile of transmissionsinferredfromobservedtransmissionpairsTheseincludebothsamplingbiasesandself-isolationorpublichealthinterventions.

Incubation period: = 3 days = 5.5 days = 9 days average

0.3

0.6

0.9

1.2

0 5 10 15 20days post infection

rela

tive

prob

abilit

y of

tran

smis

sion

A

−10 −5 0 5 10days from onset of symptoms

B



https://doi.org/10.1101/2020.09.04.20188516

10

Themoretimehaspassedsinceanindividualbecameinfected,themorelikelytheyaretohavedevelopedsymptomsorhaveapositivetestresult(eitherthroughmasstestingorasatracedcontact),andthusthemorelikelytheyaretohavebeguntakingprecautionsto avoid transmitting the virus. Hence, inferred distributions of transmission eventscouldbeprematurelytruncatedrelativetothedistributionthatwouldbeobservedwithnointerventions,andthereforedifferfromtheprofileofpurelybiologicalinfectiousnessovertime.

Suchepidemiologicalbiasesalsoaffecttherighttailofthedistributionofserialintervals.Inparticular,theserialintervalcanchangeduetointerventions(Alietal.2020)(Sunetal,personalcommunication)asitdependsstronglyontimetoisolation(Bietal.2020).Thesebiasescannotbedisentangledusingdatafromtransmissionpairsonly,butrequireinformationondatesofexposurefortracedcontactswhowereexposedbutdidnotgetinfected.Weextendedourapproachtoincludesuchinformationfrom(Chengetal.2020)(SupplementaryFigure6),fittingamodelwithdataset-dependentdecayoftransmissionsaftersymptoms(SupplementaryMethods).TheresultingdistributionofTOSTdoesnotdifferfromourpreviousfit,lyingmostlywithinitsconfidenceintervals(SupplementaryFigure7).Furthermore, the right tailof symptomatic transmissions is identical foralldatasets. These results confirm that the distribution of TOST is robust and thatepidemiological biases are similar between the studies, such as the tendency to self-isolatewhenexperiencingacuterespiratorysymptoms.

Wecaution,however,thatinfectedindividualscouldbestillinfectiouswellbeyondthetimeperiods suggestedby this epidemiological analysis.Viral loads fromnasal swabsprovidesubstantialevidenceofaninfectiousperiodaftersymptomonsetlongerthanthe3-4days inferredhere.High viral loads have been observed for at least aweek aftersymptoms(Wölfeletal.2020;Panetal.2020;Heetal.2020).Thecrucialdeterminantofinfectiousnesshoweveristheprobabilityofsheddingviablevirus,whichdecaysrapidlyafter5-10days(Wölfeletal.2020;Bullardetal.2020).However,SupplementaryFigure7 clearly shows thatbothviral loadand theprobabilityof viablevirus isolation frommultiplestudies(Aronsetal.2020;vanKampenetal.2020)decaymoreslowlythanourepidemiologicalobservationssuggest.Resolutionofthismismatchislikelyaccountedforbytheincreasedcompliancetoisolationafteronsetofsymptoms,discussedabove.

Fractions of pre-symptomatic and early symptomatic transmissions

AkeyfeatureofCOVID-19spreadispre-symptomatictransmission.Severalstudieshaveestimated its fraction by assuming time to symptoms and time to transmission areindependent(Ferrettietal.2020;Caseyetal.2020).Aswehaveshown,thisassumptionisnotsupportedbydata:transmissioneventsarecloselytiedtosymptomonset.Also,transmissiononthedayofsymptomonsetisnotnecessarilypre-symptomaticandshouldbeconsideredseparately.Hereweassess thecontributionofstrictlypre-symptomatictransmissionusingtwodifferentapproaches.

First,weestimatedthefractionoftransmissiononeachindividualdaybydiscretizingtheTOST distribution and considering the part of the distribution that corresponds tonegative times, i.e. the fraction of transmission events that occur before the day ofsymptomonset(Figure4).



https://doi.org/10.1101/2020.09.04.20188516

11

The fraction of strictly pre-symptomatic transmissions (TOST

12

16-32%), although this value is likely to be affected by self-isolation and non-pharmaceuticalinterventionsasdiscussedbefore.

The above results demonstrate the importance of implementing non-pharmaceuticalinterventions to reduce pre-symptomatic transmission, such as mass testing, contacttracingandphysicaldistancing.

TheyalsounderlinetheimportanceofstrictinfectioncontrolmeasuresatthefirstsignofevenmildsymptomspotentiallyrelatedtoCOVID-19(suchascough,fever,fatigueoranosmia),inordertoreduceearlysymptomatictransmission.Accordingtoourresults,perfect isolation of cases from onset of symptoms would stop twice as manytransmissions compared to isolation from the second day after onset of symptoms,relative to a baseline with no intervention at all (excluding transmissions from fullyasymptomatic individuals). Self-isolation of symptomatic individuals is thereforeespeciallyimportantforthefirsttwodays.

Instant, universal, and perfect self-isolation, including from family members, ischallenging, given the low specificity of early COVID-19 symptoms and the highprevalenceof respiratoryviruseswithsimilarsymptomsbetweenautumnandspring(Mennietal.2020).Nevertheless, if low-costgoodpractices thatarewidelyadvisableirrespectiveofsymptoms-wearingafacemask,increasingspatialdistance,practicingenhanced hygiene (especially hand hygiene), and limiting social contacts (includingstayingawayasmuchaspossiblefromoffices,schools,publictransport,andclosedpublicspaces)-werefollowedstrictlyatthefirstonsetofsymptoms,evenifmild,thiscouldhave a substantial impact on the epidemic. Such a policy would greatly depend oncomplianceandcollaborationfromthepublic.Symptomtrackerapps(Drewetal.2020)could play a role in enhancing public awareness of mild COVID-19 symptoms andcompliance.Asa furtheradvantage, thispolicy couldalso reduce theburdenofotherrespiratoryviruses.

Reducing barriers to testing, and increasing the speed of results is also critical;masstestingwithhome-basedorpoint-of-carerapidtestingcouldhelp individualsrespondappropriatelyandquicklytoonsetofmildsymptoms(Larremoreetal.2020).Likewise,exposurenotificationbycontacttracing,andanyinformationthatcanbeprovidedthatwillhelpindividualsgaugetheirlocalrisk,willhelpindividualscorrectlyinterprettheonsetofinitialsymptomsthatmightbeverynon-specificatinitialonset.

Discussion

Wehavepresentedanin-depthanalysisofthetimingoftransmissionfromaselectionofthemost informativedatasetsof transmissionpairs currentlyavailable.The resultingpictureofthetemporalinfectiousnessprofileofCOVID-19hassomeclearconsequencesintermsofpolicy.

The most immediate consequences concern the assessment of the transmission riskassociated to contacts for both manual and digital tracing or exposure notificationapproaches.Contact tracingguidelines fromtheCDC(CDC2020)andtheWHO(WHO2020)supporttracingofcontactsuptotwodaysbeforetheonsetofsymptomsor,forasymptomatic individuals, before a positive test. For symptomatic individuals, this



https://doi.org/10.1101/2020.09.04.20188516

13

approach misses approximately 10% of all transmissions overall, but a much largerfractionforindividualswithalongerincubationperiod(SupplementaryFigure8).Hence,publichealthadviceshouldconsiderappropriately longer intervals forcontact tracingwheneveranestimateofthedateofinfectionisavailable(e.g.throughbackwardcontacttracing)anditprecedessymptomsbymorethan4-5days.

Fordigitalcontacttracing,whichreliesonalgorithmsforriskscoringthatcantakeintoaccount the time profile of infectiousness (Wilson et al. 2020), our results are highlyvaluableto informtheappropriateriskscoringalgorithm.Theyshowthat thedateofonsetofsymptomsfortheindexcaseisacriticalpieceofinformationforthealgorithm,whichshouldbecollectedpreferablywithintheappitself,orbypublichealthofficialsatthetimethecaseisconfirmed.

Beforesymptomonset,relativetransmissionprobabilitiesestimatedherecanbeusedasaproxyforinfectiousness,i.e.thedegreeofdangerfromagivenexposure.Aftersymptomonset,riskscoresshouldtakeintoaccountthatthedistributioninferredhereislikelytounderestimate infectiousness.Wenotethatquantitativetreatmentof infectiousness isonly possible in early versions of the Google/Apple exposure notification system;unfortunately,recentversionsdonotpermitmorethantwolevelsofinfectiousness.

Theprofileofinfectiousnesspossiblydependsalsoonotherparameters,suchasinfectionseverity and age. The infectiousness profile for fully asymptomatic individuals isunknown.Forsymptomaticindividuals,thelimiteddataavailabledonotsuggestastrongdependenceonage(Alietal.2020;Furuseetal.2020),butfurtherstudiesareneeded.

The definitionof the date of onset of symptoms suffers fromuncertainties related toambiguitiesinthechoiceofthesetofsymptomsassociatedtoCOVID-19,thetimeofonsetof different symptoms, and the uncertainties in their recall. All these sources ofuncertainty are implicitly present in our study as well. Given a known, fixed, andidentifiable set of symptoms, the date of onset of symptoms can be retrieved withreasonable precision. However, the lack of specificity for COVID-19 symptoms,internationalvariationinrecognisedsymptoms,andrelianceonpatients'recollectionsall present challenges. The date of infection often has an even greater degree ofuncertainty due to the challenges in identifying infectors (who could be non-symptomatic)andinassessingthenumberanddurationofexposures.WhentheprofileofinfectiousnessasafunctionofTOSTisusedforriskscoring,uncertaintiesinthedateof symptom onset should be taken into account (e.g. averaging the index’s expectedinfectiousnessat thetimeofexposureoverthewindowofpossible timesofsymptomonset).

The large fraction of transmissions that occur either before or shortly after onset ofsymptomsconfirmsthatisolationofcasesmorethan2daysafteronsetofsymptomsisinsufficient to control the epidemic. Physical distancing, mask wearing, communitytestingandcontacttracingarekeynon-pharmaceuticalinterventionsthatareabletostoptransmissionsbeforeandaroundtheonsetofsymptoms,andshouldbeincludedinanyeffectivestrategyagainstCOVID-19.

Currentphysicaldistancingpoliciesinmanycountriesalreadyincludeself-isolationafterCOVID-19symptoms, reductionof social interactions, anduseof facemasks inpublicplaces. Our results on early symptomatic transmission underline the importance offollowingexistingguidelinesasstrictlyaspossibleforthefirsttwodaysofsymptoms,



https://doi.org/10.1101/2020.09.04.20188516

14

evenifsymptomsaremildoritisunclearwhethertheyarecompatiblewithCOVID-19.Apolicybasedonreinforcingofficialadviceorsuggestingtotakeextraprecautionsforthefirsttwodaysofsymptomsisadvisableandlikelybeneficialwithminoreconomicandsocialcosts.

Materials and Methods

Relation between generation time, incubation period and TOST The generation time 𝑡O, incubation period 𝑡( and time from onset of symptoms totransmission(TOST)𝑡+,* bydefinitionsatisfytheequation

𝑡O = 𝑡( + 𝑡+,*

IntermsofPearson’scorrelationbetweentheseepidemiologicalvariables,thisimplies

𝑐𝑜𝑟(𝑡O, 𝑡() =𝑠𝑑(𝑡()𝑠𝑑(𝑡O)

+ 𝑐𝑜𝑟(𝑡+,*, 𝑡()𝑠𝑑(𝑡+,*)𝑠𝑑(𝑡O)

If the generation time is independent of the incubation period, this would imply ananticorrelationbetweenthelatterandtheTOST,i.e.

𝑐𝑜𝑟(𝑡O, 𝑡() = 0 ⇒ 𝑐𝑜𝑟(𝑡+,*, 𝑡() = −𝑠𝑑(𝑡()𝑠𝑑(𝑡+,*)

Ontheotherhand, if theTOSTis independentof the incubationperiod, this impliesapositivecorrelationbetweengenerationtimeandincubationperiod

𝑐𝑜𝑟(𝑡+,*, 𝑡() = 0 ⇒ 𝑐𝑜𝑟(𝑡O, 𝑡() =𝑠𝑑(𝑡()𝑠𝑑(𝑡O)

Therefore, if index cases’ incubation periods correlate more strongly with theirgenerationtimes,thissuggestsinfectiousnessisdrivenmorestronglybyTOST;iftheycorrelate more strongly with TOST, this suggests that infectiousness is driven morestronglybytimesinceinfection.Equivalently,ifamodelwithindependentdistributionsforTOSTandincubationperiodbetterdescribesthepatternofinfectiousnessinthedatathanonewithindependentgenerationtimeandincubationperiod,thisstronglysuggestsa correlation between the generation time and the incubation period of the disease.Assuming no correlation in the incubation periods of source and recipient (noheritability),itwouldalsoimplyanullcorrelationbetweentheincubationperiodofthesourceandtheserialinterval:

𝑐𝑜𝑟(𝑡+,*, 𝑡() = 0 ⇒ 𝑐𝑜𝑟(𝑡,, 𝑡() ∝ 𝑐𝑜𝑣(𝑡,, 𝑡() = 𝑐𝑜𝑣(𝑡+,*, 𝑡() + 𝑐𝑜𝑣(𝑡′(, 𝑡() = 0

Wedefinethedistributionsfor𝑡O,𝑡( and𝑡+,* tobe𝑝O,𝑝( and𝑝+,*respectively.Itiswellknown that the generation time distribution 𝑝O(𝑡) plays a key role in the renewalequationforincidence𝐼(𝑡) = 𝑅X ∫ 𝑑𝜏𝑝O(𝜏)𝐼(𝑡 − 𝜏)

ZX (WallingaandLipsitch2007;Fraser

2007). Similarly, the TOST distribution 𝑝+,*(𝑡|𝑡() for a specific incubation period 𝑡( appears naturally in an alternative renewal equation relating the number of newly



https://doi.org/10.1101/2020.09.04.20188516

15

symptomaticindividualsattime𝑡withincubationperiod𝑡(, 𝐶(𝑡, 𝑡(),tothenumberofnewinfectionsattime𝑡frominfectorswithincubationperiod𝑡( ,𝐼(𝑡, 𝑡():

𝐼(𝑡, 𝑡() = 𝑅X [ 𝑑𝜏𝑝+,*(𝜏|𝑡()𝐶(𝑡 − 𝜏, 𝑡()Z

2Z

Theansatzof𝐼(𝑡, 𝑡()exponentiallygrowingwith𝑡leadstoanalternativeversionoftheEuler-LotkaequationrelatingR0andindividualtransmissiontimingtotheexponentialgrowthrater:

1𝑅X

= [ 𝑑𝑝((𝑡()𝑒2\*BZ

2Z⋅ [ 𝑑𝜏𝑝+,*(𝜏|𝑡()𝑒2\C

Z

X

Thisequationneglectsasymptomaticinfections.

Data and datasets Estimationsofgenerationtimeoftenuseinformationonthedatesofonsetofsymptomsfor both index and secondary cases from transmission pairs (i.e.the empirical serialintervals),combinedwithknowledgeoftheincubationperioddistribution(Ferrettietal.2020; Ganyani et al. 2020). However, an implicit assumption in this approach isindependencebetweenincubationperiodandgenerationtime.Sincethisispreciselytheassumptionbeing tested in thiswork,we restrictedouranalysis tomore informativedatasets. To avoid issues with misassignment of the index case, we discardedtransmissionpairsinclusterswithmultiplepossibleindexcases(exceptforpairsfrom(Ferrettietal.2020)whoalreadyconsideredthisissue).

Foradirectassessmentoftherelationshipbetween𝑡( ,𝑡Oand𝑡+,* ,informationontimingof exposure forboth indexandsecondary case isneeded, aswell asdateof symptomonsetfortheindexcase.Wewereabletofindonlytwodatasetsthatprovideboththedatesofonsetofsymptomsand(partial)informationonexposureintervalsforboththeindexcaseandthesecondarycase,namely(Ferrettietal.2020)(40pairsfromdifferentgeographicareas),and(Xiaetal.2020)(32pairsfromChina).

TofurtherimprovetheaccuracyoftheinferreddistributionofTOST,wealsoincludeddatasetsprovidingdatesofonsetofsymptomsfortheindexcasesaswellasintervalsofexposure for the secondary cases,namely (Heet al. 2020) (66pairs fromChina)and(Chengetal.2020)(18pairs fromTaiwan,excludingasymptomaticsecondarycases).Thelatteralsoprovidesdatesofonsetofsymptomsandintervalsofexposureforcontactsthatdidnotleadtoinfections(2740pairs).

As a check of robustness of our selection of datasets,we also includeddata on serialintervalsfrom(Zhangetal.2020)(35pairsfromChina).Therecouldbesomeoverlapamong the three datasets of Chinese pairs; however, the empirical serial intervaldistributionsaresufficientlydifferenttoassumethatanyoverlaprepresentsaminorityoftransmissionpairs.

For the incubation period, we considered a meta-distribution obtained by averagingsevenlognormaldistributionsreportedintheliterature(Bietal.2020;Laueretal.2020;Lietal.2020;Lintonetal.2020;Maetal.2020;Zhangetal.2020;Jiangetal.2020).Theprobability of onset of symptoms 𝑃((t) at day t was obtained by integrating thisdistributionbetweent-0.5andt+0.5.Totesttherobustnessoftheresults,wereplicated



https://doi.org/10.1101/2020.09.04.20188516

16

themusinga lognormaldistributionwithmean5.42daysandstandarddeviation2.7days,followingthemeta-analysis(McAloonetal.2020).Thelatterprovidedaworsefittoourdata(SupplementaryTable5),butconfirmedallourconclusions;inpractice,thedifferencebetweentheinferreddistributionswassmall(SupplementaryFigure5).

Likelihood WeusedamaximumcompositelikelihoodapproachsimilartopreviousworkonCOVID-19(Ferrettietal.2020;Heetal.2020).Assumingthatthetransmissionprobabilitypercontactperdayissmall,thelikelihoodfunctionforatransmissionpairis

𝐿*\`a,(𝛩, 𝛽) ∝ 𝛽 d 𝑒\eB𝑃((𝑑, − 𝑑()fg

*Bhfi

d 𝑊(𝑑′(|𝑑(, 𝑑,, 𝛩)𝑃((𝑑′, − 𝑑′()fkg

*kBhfki

where𝑒l, 𝑒maretheextremesoftheintervalofexposurefortheindexcase,𝑑( and𝑑,arethedatesofinfectionandonsetofsymptomsfortheindexcase,and𝑒′l, 𝑒′m, 𝑑′(, 𝑑′,arethesamequantitiesforthesecondarycase.Theparameters𝛽(absoluteinfectiousness)and𝛩(setofparametersofthetimedistribution)dependonthedataset.Weconsideredmultiple choices for the discretised infectiousness profile𝑊(𝑑′(|𝑑(, 𝑑, 𝛩) = 𝛺O*(𝑑′( −𝑑(|𝛩)and𝑊(𝑑′(|𝑑, 𝑑,, 𝛩) = 𝛺opqo(𝑑′( − 𝑑,|𝛩).Thegrowthrate𝑟of theepidemicwastaken to be 0.14/day for those transmission pairs sampled from the early Chineseoutbreakasexplainedin(Ferrettietal.2020),and0otherwise.Thefactor𝑒\eB weightsanotherwiseuniformdistributionfor𝑑( withintheexposurewindow[𝑒l,𝑒m],tocorrectforthefactthatgrowingincidenceinthewiderpopulationmakesmorerecentinfectionmorelikely(exceptwhenconditioningonaknowninfector,asforthesecondarycase).

Finally,thelikelihoodistheproductoftheindividuallikelihoodsoveralltransmissionpairs.Fortheinclusionofcase-contactpairsfrom(Chengetal.2020)wheretransmissiondid not occur, each such pair contributes a multiplicative factor 𝐿a+*(𝛩, 𝛽) =𝑒𝑥𝑝s−𝛽∑ 𝛺opqo(𝑑′( − 𝑑,|𝛩)

fkg*kBhfki utothelikelihood.

Choice of distributions For the generation time, we tested lognormal, gamma and Weibull distributionspreviously used in other studies, as well as generalised gamma, Gompertz, inversegamma,log-logistic,Frechet,Beta’,andLevydistributions.Discretiseddistributionsasafunctionofthenumberofdaysdwereobtainedbyintegratingeachdistributionbetweend-0.5andd+0.5.

ForTOST,weconsideredthenormaldistribution,distributionswithmoreweightinthetails(rescaledStudent’st,rescaledCauchy),andasymmetricdistributionswithGaussianand exponential tails (skew-normal, skew-logistic). We considered both the naivedistributionandaversiontruncatedatthetimeofinfection(SupplementaryTable5);thedifferencebetweeninferredshapeswassmall(SupplementaryFigure5).

FortheanalysisoftheTOSTdistributionwithdifferenttails,weconsideredarangeofshifted and rescaled symmetric functions (normal, generalised normal, Student’s t,Cauchy) and wemodelled the left and right side of the peak separately, assuming acontinuousprobabilitydensity.



https://doi.org/10.1101/2020.09.04.20188516

17

Finally,wemodelled several options for jointdistributions by rescaling the values ofTOSTdependingontheincubationperiod.Morespecifically,weeitherrescaledtheTOSTeitherrelativetotheonsetofsymptomsortothelocationparameterofthedistribution,andwe rescaled either both tails or the left tail only.We alsoperformed somemorecomplex rescalings (Supplementary Table 5 and Supplementary Methods). Note thatwhen conditioning on the incubation period, the left tail of TOST distributions wastruncatedatthetimeofinfection.

Bayesian reconstruction of timing of transmission for individual pairs

Foreachtransmissionpair,weassumedanequalpriorprobabilityof transmissiononany given day. The pair’s posterior probability of pre-symptomatic transmissionthereforeisthelikelihoodoftransmissionconditionalonbeingpre-symptomatic,dividedby the overall likelihood of transmission. To estimate the uncertainty on the overallfractionofpre-symptomatictransmissions,firstweresampledthesamenumberofpairsat random with replacement, then we assigned each pair as pre-symptomatictransmissionornotaccordingtotheabovementionedposterior;werepeatedtheprocess10,000timestoobtainthecorrespondingempiricaldistribution.Weproceeded inthesamewayforearlyandlatesymptomatictransmissions.

Acknowlegments WethankKatrinaLythgoeandtheOxfordPathogenDynamicsGroupforusefuldiscussions.ThestudywasfundedbyanawardfromtheLiKaShingFoundationtoCF.Thefundersofthestudyhadnoroleinstudydesign,datacollection,dataanalysis,datainterpretation,orwritingofthereport.

References

Ali,SheikhTaslim,LinWang,EricH.Y.Lau,Xiao-KeXu,ZhanweiDu,YeWu,GabrielM.Leung,andBenjamin J. Cowling. 2020. “Serial Interval of SARS-CoV-2Was Shortened over Time byNonpharmaceuticalInterventions.”Science,July.https://doi.org/10.1126/science.abc9004.

Anglemyer,Andrew,TheresaH.M.Moore,LisaParker,TimothyChambers,AliceGrady,KelliaChiu,Matthew Parry,MagdalenaWilczynska, Ella Flemyng, and Lisa Bero. 2020. “DigitalContact Tracing Technologies in Epidemics: A Rapid Review.” Cochrane Database ofSystematic Reviews , no. 8.https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013699/abstract.

Arons,MelissaM.,KellyM.Hatfield,SujanC.Reddy,AnneKimball,AllisonJames,JesicaR.Jacobs,JoanneTaylor,etal.2020.“PresymptomaticSARS-CoV-2InfectionsandTransmissioninaSkilledNursingFacility.”TheNewEnglandJournalofMedicine382(22):2081–90.

Ashcroft,Peter,JanaS.Huisman,SonjaLehtinen,JudithA.Bouman,ChristianL.Althaus,RolandR.Regoes,andSebastianBonhoeffer.2020.“COVID-19InfectivityProfileCorrection.”SwissMedicalWeekly.arxiv.org.

Bar-On,YinonM.,AviFlamholz,RobPhillips,andRonMilo.2020.“SARS-CoV-2(COVID-19)bytheNumbers.”eLife9(April).https://doi.org/10.7554/eLife.57309.

Bi,Qifang,YongshengWu,ShujiangMei,ChenfeiYe,XuanZou,ZhenZhang,XiaojianLiu,etal.2020.“EpidemiologyandTransmissionofCOVID-19in391Casesand1286ofTheirCloseContactsinShenzhen,China:ARetrospectiveCohortStudy.”TheLancetInfectiousDiseases20(8):911–19.

Braithwaite, Isobel, Thomas Callender, Miriam Bullock, and Robert W. Aldridge. 2020.“Automated and Partly Automated Contact Tracing: A Systematic Review to Inform theControlofCOVID-19.”TheLancetDigitalHealth,August.https://doi.org/10.1016/S2589-7500(20)30184-9.

Buitrago-Garcia,DianaC.,DianneEgli-Gany,MichelJ.Counotte,StefanieHossmann,HiraImeri,



https://doi.org/10.1101/2020.09.04.20188516

18

Aziz Mert Ipekci, Georgia Salanti, and Nicola Low. 2020. “Asymptomatic SARS-CoV-2Infections: A Living Systematic Review and Meta-Analysis.” Epidemiology. medRxiv.https://doi.org/10.1101/2020.04.25.20079103.

Bullard,Jared,KerryDust,DuaneFunk,JamesE.Strong,DavidAlexander,LaurenGarnett,CarlBoodman,etal.2020.“PredictingInfectiousSARS-CoV-2fromDiagnosticSamples.”ClinicalInfectiousDiseases:AnOfficialPublicationoftheInfectiousDiseasesSocietyofAmerica,May.https://doi.org/10.1093/cid/ciaa638.

Casey, Miriam, John Griffin, Conor G. McAloon, Andrew W. Byrne, Jamie M. Madden, DavidMcEvoy, Aine B. Collins, et al. 2020. “Pre-Symptomatic Transmission of SARS-CoV-2Infection: A Secondary Analysis Using Published Data.” Epidemiology. medRxiv.https://doi.org/10.1101/2020.05.08.20094870.

CDC.2020.“COVID-19ContactTracingCommunicationsToolkitforHealthDepartments.”August21,2020.https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing-comms.html.

Cheng,Hao-Yuan,Shu-WanJian,Ding-PingLiu,Ta-ChouNg,Wan-TingHuang,Hsien-HoLin,andTaiwan COVID-19 Outbreak Investigation Team. 2020. “Contact Tracing Assessment ofCOVID-19TransmissionDynamicsinTaiwanandRiskatDifferentExposurePeriodsBeforeand After Symptom Onset.” JAMA Internal Medicine, May.https://doi.org/10.1001/jamainternmed.2020.2020.

Drew, David A., Long H. Nguyen, Claire J. Steves, Cristina Menni, Maxim Freydin, ThomasVarsavsky, CaroleH. Sudre, etal.2020. “Rapid ImplementationofMobileTechnology forReal-TimeEpidemiologyofCOVID-19.”Science368(6497):1362–67.

Du,Zhanwei,XiaokeXu,YeWu,LinWang,BenjaminJ.Cowling,andLaurenAncelMeyers.2020.“SerialIntervalofCOVID-19amongPubliclyReportedConfirmedCases.”EmergingInfectiousDiseases26(6):1341–43.

Farronato,Chiara,MarcoIansiti,MarcinBartosiak,StefanoDenicolai,LucaFerretti,andRobertoFontana.2020.“HowtoGetPeopletoActuallyUseContact-TracingApps.”HarvardBusinessReview, July 15, 2020. https://hbr.org/2020/07/how-to-get-people-to-actually-use-contact-tracing-apps.

Ferretti, Luca, ChrisWymant,Michelle Kendall, Lele Zhao, Anel Nurtay, Lucie Abeler-Dörner,Michael Parker, David Bonsall, and Christophe Fraser. 2020. “Quantifying SARS-CoV-2TransmissionSuggestsEpidemicControlwithDigitalContactTracing.”Science368(6491).https://doi.org/10.1126/science.abb6936.

Fraser, Christophe. 2007. “Estimating IndividualandHouseholdReproductionNumbers inanEmergingEpidemic.”PloSOne2(8):e758.

Fraser,Christophe,StevenRiley,RoyM.Anderson,andNeilM.Ferguson.2004. “FactorsThatMakeanInfectiousDiseaseOutbreakControllable.”ProceedingsoftheNationalAcademyofSciencesoftheUnitedStatesofAmerica101(16):6146–51.

Furuse,Yuki,EiichiroSando,NahoTsuchiya,ReikoMiyahara,IkkohYasuda,YuraK.Ko,MayukoSaito, et al. 2020. “Clusters of Coronavirus Disease in Communities, Japan, January-April2020.”EmergingInfectiousDiseases26(9).https://doi.org/10.3201/eid2609.202272.

Ganyani,Tapiwa,CécileKremer,DongxuanChen,AndreaTorneri,ChristelFaes,JaccoWallinga,andNielHens.2020.“EstimatingtheGenerationIntervalforCoronavirusDisease(COVID-19)BasedonSymptomOnsetData,March2020.”EuroSurveillance:BulletinEuropeenSurLes Maladies Transmissibles = European Communicable Disease Bulletin 25 (17).https://doi.org/10.2807/1560-7917.ES.2020.25.17.2000257.

Griffin, JohnM.,AineB. Collins,KevinHunt,DavidMcEvoy,MiriamCasey,AndrewW.Byrne,Conor G. McAloon, Ann Barber, Elizabeth Ann Lane, and Simon J. More. 2020. “A RapidReview of Available Evidence on the Serial Interval and Generation Time of COVID-19.”Epidemiology.medRxiv.https://doi.org/10.1101/2020.05.08.20095075.

He,Xi,EricH.Y.Lau,PengWu,XilongDeng,JianWang,XinxinHao,YiuChungLau,etal.2020.“TemporalDynamicsinViralSheddingandTransmissibilityofCOVID-19.”NatureMedicine26(5):672–75.

Hinch,R.,W.Probert,A.Nurtay,M.Kendall,C.Wymant,M.Hall,K.Lythgoe,etal.2020.“EffectiveConfigurationsofaDigtalContactTracingApp:AReporttoNHSX(2020).”AvailableHere.



https://doi.org/10.1101/2020.09.04.20188516

19

Jiang,X.,Y.Niu, X.Li,L.Li,W.Cai,Y.Chen,andB.Liao.2020. “Isa14-DayQuarantinePeriodOptimal for Effectively Controlling Coronavirus Disease 2019 (COVID-19)?” medRxiv.https://www.medrxiv.org/content/10.1101/2020.03.15.20036533v1.abstract.

Kampen,JeroenJ.A.van,DavidA.M.C.vandeVijver,PieterL.A.Fraaij,BartL.Haagmans,MartM.Lamers,NisreenOkba,JohannesP.C.vandenAkker,etal.2020.“SheddingofInfectiousVirusinHospitalizedPatientswithCoronavirusDisease-2019(COVID-19):DurationandKeyDeterminants.” Infectious Diseases (except HIV/AIDS). medRxiv.https://doi.org/10.1101/2020.06.08.20125310.

Kretzschmar,MirjamE.,GannaRozhnova,MartinC.J.Bootsma,MichielvanBoven,JannekeH.H.M.vandeWijgert,andMarcJ.M.Bonten.2020.“ImpactofDelaysonEffectivenessofContactTracingStrategiesforCOVID-19:AModellingStudy.”TheLancet.PublicHealth5(8):e452–59.

Kucharski,AdamJ.,PetraKlepac,AndrewJ.K.Conlan,StephenM.Kissler,MariaL.Tang,HannahFry, Julia R. Gog, W. John Edmunds, and CMMID COVID-19 working group. 2020.“Effectivenessof Isolation,Testing,ContactTracing,andPhysicalDistancingonReducingTransmissionof SARS-CoV-2 inDifferent Settings:AMathematicalModelling Study.”TheLancetInfectiousDiseases,June.https://doi.org/10.1016/S1473-3099(20)30457-6.

Larremore,DanielB.,BryanWilder,EvanLester,SorayaShehata,JamesM.Burke,JamesA.Hay,Milind Tambe, Michael J. Mina, and Roy Parker. 2020. “Test Sensitivity Is Secondary toFrequencyandTurnaroundTimeforCOVID-19Surveillance.”medRxiv:ThePreprintServerforHealthSciences,June.https://doi.org/10.1101/2020.06.22.20136309.

Lauer,StephenA.,KyraH.Grantz,QifangBi,ForrestK.Jones,QuluZheng,HannahR.Meredith,AndrewS.Azman,NicholasG.Reich, and JustinLessler. 2020. “The IncubationPeriodofCoronavirusDisease2019(COVID-19)FromPubliclyReportedConfirmedCases:EstimationandApplication.”AnnalsofInternalMedicine172(9):577–82.

Lavezzo,Enrico,ElisaFranchin,ConstanzeCiavarella,GinaCuomo-Dannenburg,LuisaBarzon,ClaudiaDelVecchio,LuciaRossi,etal.2020.“SuppressionofaSARS-CoV-2OutbreakintheItalianMunicipalityofVo’.”Nature584(7821):425–29.

Lee,Seungjae,TarkKim,EunjungLee,CheolguLee,HojungKim,HeejeongRhee,SeYoonPark,etal. 2020. “Clinical Course and Molecular Viral Shedding Among Asymptomatic andSymptomaticPatientsWithSARS-CoV-2InfectioninaCommunityTreatmentCenterintheRepublic of Korea.” JAMA Internal Medicine, August.https://doi.org/10.1001/jamainternmed.2020.3862.

Linton,NatalieM.,TetsuroKobayashi,YichiYang,KatsumaHayashi,AndreiR.Akhmetzhanov,Sung-MokJung,BaoyinYuan,RyoKinoshita,andHiroshiNishiura.2020.“IncubationPeriodandOtherEpidemiologicalCharacteristicsof2019NovelCoronavirusInfectionswithRightTruncation:AStatisticalAnalysisofPubliclyAvailableCaseData.”JournalofClinicalMedicineResearch9(2):538.

Li,Qun,XuhuaGuan,PengWu,XiaoyeWang,LeiZhou,YeqingTong,RuiqiRen,etal.2020.“EarlyTransmissionDynamicsinWuhan,China,ofNovelCoronavirus–InfectedPneumonia.”TheNewEnglandJournalofMedicine382(13):1199–1207.

Madewell,ZacharyJ.,YangYang,IraM.Longini,M.ElizabethHalloran,andNatalieE.Dean.2020.“Household Transmission of SARS-CoV-2: A Systematic Review and Meta-Analysis ofSecondary Attack Rate.” medRxiv : The Preprint Server for Health Sciences, July.https://doi.org/10.1101/2020.07.29.20164590.

Ma,Shujuan,JiayueZhang,MinyanZeng,QingpingYun,WeiGuo,YixiangZheng,ShiZhao,MaggieH.Wang,andZuyaoYang.2020.“EpidemiologicalParametersofCoronavirusDisease2019:APooledAnalysisofPubliclyReportedIndividualDataof1155CasesfromSevenCountries.”Medrxiv.https://www.medrxiv.org/content/10.1101/2020.03.21.20040329v1.abstract.

May,R.M.,A.R.McLean, J.Pattison,R.A.Weiss,RoyM.Anderson,ChristopheFraser,AzraC.Ghani,etal.2004.“Epidemiology,TransmissionDynamicsandControlofSARS:The2002–2003Epidemic.”PhilosophicalTransactionsoftheRoyalSocietyofLondon.SeriesB,BiologicalSciences359(1447):1091–1105.

McAloon,Conor,ÁineCollins,KevinHunt,AnnBarber,AndrewW.Byrne,FrancisButler,Miriam



https://doi.org/10.1101/2020.09.04.20188516

20

Casey,etal.2020.“IncubationPeriodofCOVID-19:ARapidSystematicReviewandMeta-AnalysisofObservationalResearch.”BMJOpen10(8):e039652.

Menni,Cristina,AnaM.Valdes,MaximB.Freidin,CaroleH.Sudre,LongH.Nguyen,DavidA.Drew,SajaysuryaGanesh,etal.2020.“Real-TimeTrackingofSelf-ReportedSymptomstoPredictPotentialCOVID-19.”NatureMedicine26(7):1037–40.

Nishiura,Hiroshi,NatalieM.Linton,andAndreiR.Akhmetzhanov.2020.“SerialIntervalofNovelCoronavirus(COVID-19)Infections.”InternationalJournalofInfectiousDiseases:IJID:OfficialPublicationoftheInternationalSocietyforInfectiousDiseases93(April):284–86.

Pan,Yang,DaitaoZhang,PengYang,LeoL.M.Poon,andQuanyiWang.2020.“ViralLoadofSARS-CoV-2inClinicalSamples.”TheLancetInfectiousDiseases20(4):411–12.

Park,SangWoo,KaiyuanSun,DavidChampredon,MichaelLi,BenjaminM.Bolker,David J.D.Earn, Joshua S. Weitz, Bryan T. Grenfell, and Jonathan Dushoff. 2020. “Cohort-BasedApproach to Understanding the Roles of Generation and Serial Intervals in ShapingEpidemiological Dynamics.” medRxiv.https://www.medrxiv.org/content/10.1101/2020.06.04.20122713v1.abstract.

Peak,CoreyM.,LaurenM.Childs,YonatanH.Grad,andCarolineO.Buckee.2017. “ComparingNonpharmaceuticalInterventions forContainingEmergingEpidemics.”Proceedingsof theNationalAcademyofSciencesoftheUnitedStatesofAmerica114(15):4023–28.

Pollán, Marina, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Miguel A. Hernán,Mayte Pérez-Olmeda, Jose L. Sanmartín, et al. 2020. “Prevalence of SARS-CoV-2 in Spain(ENE-COVID):ANationwide,Population-BasedSeroepidemiologicalStudy.”TheLancet396(10250):535–44.

Svensson,Ake.2007.“ANoteonGenerationTimesinEpidemicModels.”MathematicalBiosciences208(1):300–311.

Tindale,LaurenC.,JessicaE.Stockdale,MichelleCoombe,EmmaS.Garlock,WingYinVenusLau,ManuSaraswat,LouxinZhang,DongxuanChen, JaccoWallinga,andCarolineColijn.2020.“Evidence for Transmission of COVID-19 prior to Symptom Onset.” eLife 9 (June).https://doi.org/10.7554/eLife.57149.

Wallinga,J.,andM.Lipsitch.2007.“HowGenerationIntervalsShapetheRelationshipbetweenGrowth Rates and Reproductive Numbers.” Proceedings. Biological Sciences / The RoyalSociety274(1609):599–604.

WHO. 2020. “Contact Tracing in the Context of COVID-19.”https://www.who.int/publications/i/item/contact-tracing-in-the-context-of-covid-19.

Wilson,AmandaM.,NathanAviles,PalomaI.Beamer,ZsomborSzabo,KaceyC.Ernst,andJoannaMasel. 2020. “Quantifying SARS-CoV-2 Infection Risk within the Apple/Google ExposureNotification Framework to Inform Quarantine Recommendations.” medRxiv.https://www.medrxiv.org/content/10.1101/2020.07.17.20156539v1.abstract.

Wölfel,Roman,VictorM.Corman,WolfgangGuggemos,MichaelSeilmaier,SabineZange,MarcelA.Müller,DanielaNiemeyer,etal.2020. “VirologicalAssessmentofHospitalizedPatientswithCOVID-2019.”Nature581(7809):465–69.

Xia,Wei, JiaqiangLiao, Chunhui Li, YuanyuanLi, XiQian,Xiaojie Sun,HongboXu, et al.2020.“TransmissionofCoronaVirusDisease2019during the IncubationPeriodMayLead toaQuarantine Loophole.” Epidemiology. medRxiv.https://doi.org/10.1101/2020.03.06.20031955.

Zhang,Juanjuan,MariaLitvinova,WeiWang,YanWang,XiaoweiDeng,XinghuiChen,MeiLi,etal.2020. “Evolving Epidemiology and TransmissionDynamics of CoronavirusDisease 2019OutsideHubeiProvince,China:ADescriptiveandModellingStudy.”TheLancet InfectiousDiseases20(7):793–802.

Zhou,Rui,FurongLi,FengjuanChen,HuaminLiu,JiazhenZheng,ChunliangLei,andXianboWu.2020. “ViralDynamicsinAsymptomaticPatientswithCOVID-19.” International JournalofInfectiousDiseases:IJID:OfficialPublicationoftheInternationalSocietyforInfectiousDiseases96(July):288–90.


https://doi.org/10.1101/2020.09.04.20188516

the timing of covid-19 transmission - medrxiv€¦ · 04/09/2020 · perpetuity. 1 the timing of...

Documents